FRA:KK2
Delisted

Sun A. Kaken . Stock Forecast

etoro logo Buy KK2
*Your capital is at risk
3.20€
+0.0200 (+0.629%)
At Close: Apr 18, 2023

KK2.F Performance

FAQ

What is the symbol for Sun A. Kaken Co., Ltd. Stock and on which exchange is it traded?
The symbol for Sun A. Kaken Co., Ltd. is KK2.F and it is traded on the FRA (Frankfurt Stock Exchange).

Should I buy or sell Sun A. Kaken Co., Ltd. Stock?
Sun A. Kaken Co., Ltd. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Sun A. Kaken Co., Ltd. Stock?
Sun A. Kaken Co., Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Sun A. Kaken Co., Ltd. Stock.

What's the current price of Sun A. Kaken Co., Ltd. Stock?
As of the end of day on the Apr 18, 2023, the price of an Sun A. Kaken Co., Ltd. (KK2.F) share was 3.20€.

What is the 52-week high and low for Sun A. Kaken Co., Ltd. Stock?
The 52-week high for Sun A. Kaken Co., Ltd. Stock is 3.74€ and the 52-week low is 2.96€.
Click to get the best stock tips daily for free!
ABOUT SUN A. KAKEN CO., LTD.
Sun A. Kaken .
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE